Mark C. Gebhardt

A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System

Mark C. Gebhardt, Martin Malawar, Douglas Pritchard · Clinical Orthopaedics and Related Research · 1993 · 2.2K citations

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

Holcombe E. Grier, Mark Krailo, Nancy J. Tarbell et al. · New England Journal of Medicine · 2003 · 1.3K citations

p53 functions as a cell cycle control protein in osteosarcomas.

Lisa Diller, J Kassel, C. Nelson et al. · Molecular and Cellular Biology · 1990 · 766 citations

Wild-type P53, Oncogenic Agent, P53 Gene +14

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2008 · 734 citations · Full text

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2005 · 711 citations · Full text